TetX is a flavin-dependent monooxygenase conferring resistance to tetracycline antibiotics

Area of Science:

• Biochemistry
• Microbiology
• Molecular Biology

Background:

• Tetracycline antibiotics are crucial for treating bacterial infections by inhibiting microbial translation.
• Antibiotic resistance mechanisms include efflux pumps and ribosomal protection.
• A novel oxygen-dependent drug destruction mechanism mediated by the enzyme TetX has been identified.

Purpose of the Study:

• To characterize the molecular mechanism of antibiotic inactivation by the TetX enzyme.
• To investigate the enzymatic activity, substrate spectrum, and resistance conferred by TetX.
• To elucidate the chemical pathway of tetracycline degradation catalyzed by TetX.

Main Methods:

• Overexpression and purification of recombinant TetX enzyme from Escherichia coli.
• In vitro enzyme activity assays using various tetracycline analogues.
• Biochemical characterization including cofactor identification (flavin adenine dinucleotide) and reaction condition optimization (molecular oxygen, NADPH).
• Mass spectrometry and Nuclear Magnetic Resonance (NMR) spectroscopy for structural elucidation of degradation products.

Main Results:

• TetX forms a stoichiometric complex with flavin adenine dinucleotide (FAD).
• The enzyme requires molecular oxygen and NADPH for catalytic activity, degrading a broad spectrum of tetracycline antibiotics.
• TetX confers in vivo resistance to tetracyclines.
• Degradation involves initial monohydroxylation at position 11a, followed by cyclization and breakdown into undefined products.

Conclusions:

• TetX is a FAD-dependent monooxygenase responsible for oxygen-dependent tetracycline antibiotic inactivation.
• This enzyme represents a novel mechanism of antibiotic resistance, potentially originating from environmental bacteria.
• The findings provide the first molecular characterization of an antibiotic-inactivating monooxygenase, expanding our understanding of antimicrobial resistance.